PubMed for id: 5300

Year	Number of Results
1996	2
1997	2
1998	2
1999	4
2000	3
2001	10
2002	14
2003	9
2004	7
2005	21
2006	18
2007	26
2008	16
2009	35
2010	25
2011	36
2012	33
2013	51
2014	34
2015	41
2016	35
2017	21
2018	28
2019	24
2020	29
2021	14
2022	14
2023	17
2024	6

1

Nuclear Phosphoproteome Reveals Prolyl Isomerase PIN1 as a Modulator of Oncogene-Induced Senescence.

Mohallem R, Aryal UK. Mohallem R, et al. Mol Cell Proteomics. 2024 Feb;23(2):100715. doi: 10.1016/j.mcpro.2024.100715. Epub 2024 Jan 10. Mol Cell Proteomics. 2024. PMID: 38216124 Free PMC article.

2

Prolyl isomerase Pin1 promotes autophagy and cancer cell viability through activating FoxO3 signalling.

Long J, Wang J, Dong Y, Yang J, Xie G, Tong Y. Long J, et al. Cell Signal. 2024 Jan;113:110940. doi: 10.1016/j.cellsig.2023.110940. Epub 2023 Oct 30. Cell Signal. 2024. PMID: 38084839 Free article.

3

Key role of PIN1 in telomere maintenance and oncogenic behavior in a human glioblastoma model.

Maggio J, Cardama GA, Armando RG, Balcone L, Sobol NT, Gomez DE, Mengual Gómez DL. Maggio J, et al. Oncol Rep. 2023 May;49(5):91. doi: 10.3892/or.2023.8528. Epub 2023 Mar 24. Oncol Rep. 2023. PMID: 36960859

4

Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complex.

Aoyama S, Kido Y, Kanamoto M, Naito M, Nakanishi M, Kanna M, Yamamotoya T, Asano T, Nakatsu Y. Aoyama S, et al. Exp Cell Res. 2023 Apr 15;425(2):113544. doi: 10.1016/j.yexcr.2023.113544. Epub 2023 Mar 9. Exp Cell Res. 2023. PMID: 36906101

5

Pin1 and Alzheimer's disease.

Malter JS. Malter JS. Transl Res. 2023 Apr;254:24-33. doi: 10.1016/j.trsl.2022.09.003. Epub 2022 Sep 23. Transl Res. 2023. PMID: 36162703 Free PMC article. Review.

6

Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies.

Wu W, Xue X, Chen Y, Zheng N, Wang J. Wu W, et al. Pharmacol Res. 2022 Oct;184:106456. doi: 10.1016/j.phrs.2022.106456. Epub 2022 Sep 16. Pharmacol Res. 2022. PMID: 36116709 Review.

7

Circulating levels of PIN1 and glucose metabolism in young people with obesity.

Bianchi M, Manco M. Bianchi M, et al. J Endocrinol Invest. 2022 Sep;45(9):1741-1748. doi: 10.1007/s40618-022-01812-8. Epub 2022 May 18. J Endocrinol Invest. 2022. PMID: 35585295

8

Association of polymorphisms in PIN1 with progression and susceptibility in gastric cancer.

Huang L, Luo R, Yang Z, Xu J, Li H, Mo Z. Huang L, et al. Future Oncol. 2022 Apr;18(13):1557-1568. doi: 10.2217/fon-2021-1240. Epub 2022 Feb 2. Future Oncol. 2022. PMID: 35105157

9

Screening of the HBx transactivation domain interacting proteins and the function of interactor Pin1 in HBV replication.

Zhou Q, Yan L, Xu B, Wang X, Sun X, Han N, Tang H, Huang F. Zhou Q, et al. Sci Rep. 2021 Jul 8;11(1):14176. doi: 10.1038/s41598-021-93584-z. Sci Rep. 2021. PMID: 34238995 Free PMC article.

10

Impact of PIN1 Inhibition on Tumor Progression and Chemotherapy Sensitivity in Colorectal Cancer.

Gholamzadeh Khoei S, Saidijam M, Amini R, Jalali A, Najafi R. Gholamzadeh Khoei S, et al. J Gastrointest Cancer. 2022 Jun;53(2):299-310. doi: 10.1007/s12029-021-00600-6. Epub 2021 Feb 13. J Gastrointest Cancer. 2022. PMID: 33580870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

514 results

Results by year